Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting strategies in the treatment of fumarate hydratase deficient renal cell carcinoma
Andrea Katharina Lindner, Gennadi Tulchiner, Andreas Seeber, et al.
Frontiers in Oncology (2022) Vol. 12
Open Access | Times Cited: 18

Showing 18 citing articles:

Altered metabolism in cancer: insights into energy pathways and therapeutic targets
Muhammad Tufail, Canhua Jiang, Ning Li
Molecular Cancer (2024) Vol. 23, Iss. 1
Open Access | Times Cited: 54
Fumarate hydratase (FH) and cancer: a paradigm of oncometabolism
Lorea Valcárcel-Jiménez, Christian Frezza
British Journal of Cancer (2023) Vol. 129, Iss. 10, pp. 1546-1557
Open Access | Times Cited: 31
Comprehensive proteogenomic characterization of rare kidney tumors
Ginny Xiaohe Li, Lijun Chen, Yi Hsiao, et al.
Cell Reports Medicine (2024) Vol. 5, Iss. 5, pp. 101547-101547
Open Access | Times Cited: 12
A chemokine network of T cell exhaustion and metabolic reprogramming in renal cell carcinoma
Renate Pichler, Peter J. Siska, Piotr Tymoszuk, et al.
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 13
Implications of Fumarate Hydratase Deficiency (FHD) and Cancer Risk: A Window into the Clinical and Oncological Implications of a Rare Disorder in Gynecology
Marco D’Indinosante, Sara Lardino, Matteo Bruno, et al.
Cancers (2025) Vol. 17, Iss. 4, pp. 573-573
Open Access
Comparison of 68Ga-FAPI-04 and 18F-FDG PET/CT in Fumarate Hydratase-Deficient Renal Cell Carcinoma
Shuhui Huang, Haoyang Liu, Hongyuan Dai, et al.
Clinical Nuclear Medicine (2024) Vol. 49, Iss. 10, pp. 931-937
Closed Access | Times Cited: 3
Clinical Characteristics of Molecularly Defined Renal Cell Carcinomas
Xinfeng Hu, Congzhu Tan, Guodong Zhu
Current Issues in Molecular Biology (2023) Vol. 45, Iss. 6, pp. 4763-4777
Open Access | Times Cited: 7
Case report: successful response to bevacizumab combined with erlotinib for a novel FH gene mutation hereditary leiomyoma and renal cell carcinoma
Xiaoming Bai, Dan Xiang, Mengxi Huang, et al.
Frontiers in Pharmacology (2024) Vol. 15
Open Access | Times Cited: 2
Genetics of enzymatic dysfunctions in metabolic disorders and cancer
Mélanie Mahé, Tiffany J. Rios-Fuller, Andrea Karolin, et al.
Frontiers in Oncology (2023) Vol. 13
Open Access | Times Cited: 6
Advanced renal cell carcinoma management: the Latin American Cooperative Oncology Group (LACOG) and the Latin American Renal Cancer Group (LARCG) consensus update
Andrey Soares, Fernando Sabino Marques Monteiro, Karine Martins da Trindade, et al.
Journal of Cancer Research and Clinical Oncology (2024) Vol. 150, Iss. 4
Open Access | Times Cited: 1
Germline and Somatic Fumarate Hydratase Testing in Atypical Uterine Leiomyomata
Lindsay Kipnis, Katelyn M. Breen, Diane R. Koeller, et al.
Cancer Prevention Research (2024) Vol. 17, Iss. 5, pp. 201-208
Closed Access | Times Cited: 1
Synchronous Seminoma of Testis and Renal Cell Carcinoma: A Rare Case Report
Stasys Auškalnis, Rasa Jančiauskienė, Urte Rimsaite, et al.
Medicina (2024) Vol. 60, Iss. 9, pp. 1553-1553
Open Access | Times Cited: 1
Complete response to fifth-line anti-PD-1 rechallenge in fumarate hydratase-mutated papillary renal cell carcinoma
Isabella Portugal, Maria Alejandra Clavijo-Salomon
npj Precision Oncology (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 1
Fumarate hydratase functions as a tumor suppressor in endometrial cancer by inactivating EGFR signaling
Yen‐Yun Wang, Anupama Vadhan, Ching-Hu Wu, et al.
Oncology Reports (2023) Vol. 50, Iss. 4
Closed Access | Times Cited: 2
Probing intratumoral metabolic compartmentalisation in fumarate hydratase-deficient renal cancer using clinical hyperpolarised13C-MRI and mass spectrometry imaging
Ines Horvat‐Menih, Ruth Casey, James Denholm, et al.
medRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Multi-targeted Tyrosine Kinase Inhibitors in the Treatment of Cancer and Neurodegenerative Disorders

Frontiers research topics (2024)
Closed Access
Recent Advances in Genitourinary Tumors: Updates From the 5th Edition of the World Health Organization Blue Book Series
Nicole C. Riddle, Vinita Parkash, Charles C. Guo, et al.
Archives of Pathology & Laboratory Medicine (2023) Vol. 148, Iss. 8, pp. 952-964
Open Access | Times Cited: 1
Hereditary predisposition to kidney cancer: cancer syndromes, multisystemic disorders, and nephropathies
Grigoriy A. Yanus, Aglaya G. Iyevleva, Evgeny N. Suspitsin, et al.
Sechenov Medical Journal (2023) Vol. 14, Iss. 2, pp. 5-20
Open Access
Page 1

Scroll to top